Clinical Trials Logo

Metastatic Endometrial Cancer clinical trials

View clinical trials related to Metastatic Endometrial Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03617679 Active, not recruiting - Clinical trials for Metastatic Endometrial Cancer

Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer

Start date: March 6, 2019
Phase: Phase 2
Study type: Interventional

This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer, after 1-2 prior lines of therapy.

NCT ID: NCT02912572 Active, not recruiting - Clinical trials for Metastatic Endometrial Cancer

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

Start date: November 14, 2016
Phase: Phase 2
Study type: Interventional

This research study is evaluating a drug called Avelumab alone and in combination with Talazoparib or Axitinib as a possible treatment for recurrent or metastatic endometrial cancer.